Home › Health, Fitness & Diet Books › False Hope: Bone Marrow Transplantation for Breast Cancer
Skip to product information
1 of 1

False Hope: Bone Marrow Transplantation for Breast Cancer

hardcover – January 25, 2007
Regular price $45.77 USD
Regular price Sale price $45.77 USD
Sale Sold out
Shipping calculated at checkout.
Secure Checkout
Quality Guaranteed
New In Stock
ISBN-13: 9780195187762 ISBN-10: 0195187768
Publisher
Oxford University Press, USA
Binding
hardcover
Published
January 25, 2007
Weight
1.5 lbs
Dimensions
2.40×16.60×24.00 cm

About this book

False Hope: Bone Marrow Transplantation for Breast Cancer by Wade M. Aubry. hardcover edition. ISBN: 9780195187762.

In the late 1980s, a promising new treatment for breast cancer emerged: high-dose chemotherapy with autologous bone marrow transplantation or HDC/ABMT. By the 1990s, it had burst upon the oncology scene and disseminated rapidly before having been carefully evaluated. By the time published studies showed that the procedure was ineffective, more than 30,000 women had received the treatment, shortening their lives and adding to their suffering. This book tells of the rise and demise of HDC/ABMT for metastatic and early stage breast cancer, and fully explores the storys implications, which go well beyond the immediate procedure, and beyond breast cancer, to how we in the United States evaluate other medical procedures, especially life-saving ones. It details how the factors that drove clinical use--patient demand, physician enthusiasm, media reporting, litigation, economic exploitation, and legislative and administrative mandates--converged to propel the procedure forward despite a lack of proven clinical effectiveness. It also analyzes the limited effect of technology assessments before randomized clinical trials evaluated decisively the procedure and the ramifications of this system on healthcare today. Sections of the book consider the initial conditions surrounding the emergence of the new breast cancer treatment, the drivers of clinical use, and the struggle for evidence-based medicine. A concluding section considers the significance of the story for our healthcare system.